← Back to Search

AI Technology for Depression and Anxiety Detection

N/A

Waitlist Available

Led By Kiran Faryar, MD, MPH

Research Sponsored by Kiran Faryar, MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to improve the identification of mental health issues like depression and anxiety in emergency departments. Researchers are using Artificial Intelligence to analyze facial expressions and tone of voice to detect these conditions. Participants will answer

Who is the study for?

This trial is for emergency department patients who may have depression or anxiety. It aims to test if AI can identify these conditions by analyzing facial expressions and tone of voice from recordings during their visit.

What is being tested?

The study tests an AI software's ability to detect signs of depression and anxiety through biometrics, using participants' audio and video responses to simple questions recorded in the emergency department.

What are the potential side effects?

There are no direct physical side effects expected from participating in this trial as it involves non-invasive recording of speech and visual patterns for analysis by AI technology.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Percentage of participants who score 10-14 on the GAD-7

Percentage of participants who score 10-14 on the PHQ-9

Percentage of participants who score 15-19 on the PHQ-9

+4 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Participants seen at University Hospitals Cleveland Medical Center Emergency DepartmentExperimental Treatment1 Intervention

Eligible patients must present with non-emergent concerns of Emergency Severity Index (ESI) level 3, 4, or 5. Patients will complete assessments and questionnaires and end with being recorded reading a story to capture facial expressions and audio cues.

Do I qualify?Apply below to find out